Current and new strategies in immunotherapy for superficial bladder cancer.

Structure	Name/CAS No.	Molecular Formula	Articles
	Bropirimine CAS:56741-95-8	C₁₀H₈BrN₃O

CMV specific cytokine release assay in whole blood is optimi...
2014-12-01
[J. Immunol. Methods 414 , 82-90, (2014)]

Bropirimine, an orally active anticancer agent for superfici...
1998-08-01
[Eur. Urol. 34(2) , 107-10, (1998)]

Paclitaxel, bropirimine and linomide: effect on growth inhib...
1998-03-01
[Methods Find. Exp. Clin. Pharmacol. 20(2) , 111-4, (1998)]

Bropirimine as neoadjuvant therapy decreases residual diseas...
1997-05-01
[Methods Find. Exp. Clin. Pharmacol. 19(4) , 261-7, (1997)]

Complexation of the interferon inducer, bropirimine, with hy...
2000-02-01
[Eur. J. Pharm. Sci. 9(4) , 381-6, (2000)]